Gesellschaftsrecht / M&A

IP / IT

Steuern

Arbeitsrecht und Vergütung für Führungskräfte

Wettbewerb

Homburger News

Homburger and 908 Devices

Homburger advised 908 Devices Inc. on its acquisition of NIRLAB

On May 4, 2026, 908 Devices Inc. (NASDAQ: MASS) announced the completion of its acquisition of Swiss-based NIRLAB SA for a combination of cash and stock, including earn-out consideration. The NIRLAB Group develops near-infrared (NIR) spectroscopy solutions for instant material identification. 908 Devices is revolutionizing chemical analysis with its simple handheld devices for vital health, safety, and defense tech applications, such as the illicit drug crisis, toxic carcinogen exposure, and global security threats.
The Homburger team advising 908 Devices Inc. comprised Andreas Müller, Olivier Bühlmann, Carlo Sulser, Luca Yousef, Fabia Starkermann and Géraldine Bär (all Corporate / M&amp;A), Luca Dal Molin and Berem Brun (both IP / IT), Reto Heuberger and Juliette Buob (both Tax), Angela Casey (Employment and Executive Compensation), and Richard Stäuber, Allegra Arnold and Giulia Meier (all Competition).

Healthcare / Life Sciences

Windward Bio

Homburger advises Windward Bio on its USD 165 m Series B Financing

On May 4, 2026, Windward Bio Group AG, a private, clinical-stage biotechnology company committed to improving outcomes for people living with serious immunological diseases, announced an upsized USD 165 m crossover financing led by OrbiMed, with participation from existing Series A investors including Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners. The financing also included new investors RA Capital Management, Janus Henderson Investors, Sanofi Ventures, and Harbour BioMed.
The Homburger team advising Windward Bio includes Margrit Marti, Andreas Müller, Lucas Forrer, Anina Preusker and Géraldine Bär (all Corporate / M&amp;A) as well as Stefan Oesterhelt and Juliette Buob (both Tax).

Géraldine
Bär

Homburger advised 908 Devices Inc. on its acquisition of NIRLAB

Homburger advises Windward Bio on its USD 165 m Series B Financing

Anordnung einer Sonderuntersuchung (Art. 697d i.V.m. Art. 697e OR)

Einsetzung eines Sonderprüfers nach Art. 697b aOR bei Täuschungsvorwürfen

Join the Team

Géraldine Bär

Karriere

Sprachen

Zulassung

Teams

GéraldineBär

Homburger advised 908 Devices Inc. on its acquisition of NIRLAB

Homburger advises Windward Bio on its USD 165 m Series B Financing

Anordnung einer Sonderuntersuchung (Art. 697d i.V.m. Art. 697e OR)

Einsetzung eines Sonderprüfers nach Art. 697b aOR bei Täuschungsvorwürfen

Join the Team

Géraldine Bär

Karriere

Sprachen

Zulassung

Teams

Géraldine
Bär